Memorial Sloan Kettering Cancer Center
Results of Phase II Clinical Trial of Cabozantinib + Nivolumab for Advanced ncRCC
By
Memorial Sloan Kettering Cancer Center
FEATURING
Chung-Han Lee
By
Memorial Sloan Kettering Cancer Center
FEATURING
Chung-Han Lee
Login to view comments.
Click here to Login